ANTERIOR CHAMBER INFLUENCE ON OCULAR ANTIGENS

前房对眼抗原的影响

基本信息

  • 批准号:
    2159522
  • 负责人:
  • 金额:
    $ 28.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-11-01 至 1995-06-30
  • 项目状态:
    已结题

项目摘要

Systemic immune responses to anterior chamber antigens are deviant in that certain types of immune effectors (delayed hypersensitivity and complement fixing antibodies) are selectively deleted and/or suppressed, whereas other effectors (cytotoxic T cells, non-complement fixing antibodies) are induced. This unique pattern of immune effectors has been termed Anterior Chamber Associate Immune Deviation (ACAID). Since it has been determined that anatomic integrity of he antigen-containing eye and the spleen is required for ACAID induction during the first 4-5 days after intracameral antigen injection of antigen, experiments have been designed to investigate the cellular and molecular bases of these requirements. Two related hypotheses will be tested experimentally: (1) A qualitatively and/or quantitatively distinct antigen-specific ACAID-inducing signal escapes into the blood from eyes into which antigen has been introduced; (2) In the spleen, the ACAID-inducing signal preferentially activates TH2 cells, which in turn impair the induction of TH1 cells that are responsible for the generation of delayed hypersensitivity and complement fixing antibodies. Recent evidence indicates that expression of immunity within the eye may also be abnormal. A third hypothesis to be tested is Local intraocular factors (cells and molecules) act to reduce intraocular expression of delayed hypersensitivity. Since alterations in induction and expression of immunity toward intraocular antigens exist, a fourth hypothesis to be tested states that Deviant immune responses (ACAID) may have beneficial or deleterious effect in the eye, leading to immune-related ocular disease. To test these hypotheses, we have devised four Specific Aims: 1. Study of the eye as a source of the ACAID-inducing signal. 2. Analyze splenic T cells to identify and study regulatory lymphocytes in ACAID. 3. Characterize immune effector cell responses in the anterior chamber of the eye. 4. Explore the possible relationships between ACAID and experimental ocular diseases. As new data accumulate concerning the unique relationship between the systemic immune system and the eye, progress should be possible in our understanding of the etiology of ocular disease in which the immune system plays an important pathogenic role. Based on this understanding, strategies can then be devised to manipulate the immune system in specific ways designed to prevent and/or treat immunopathogenic ocular diseases.
对前房抗原的全身免疫反应是不正常的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J WAYNE STREILEIN其他文献

J WAYNE STREILEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J WAYNE STREILEIN', 18)}}的其他基金

AUTOIMMUNITY ASSOCIATED WITH PIGMENT DISPERSION GLAUCOMA
与色素分散性青光眼相关的自身免疫
  • 批准号:
    6598293
  • 财政年份:
    2003
  • 资助金额:
    $ 28.51万
  • 项目类别:
RES BLDG RENOVATION: EYES
RES 大楼改造:眼睛
  • 批准号:
    6794345
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
CONTINUED RENOVATION OF RESEARCH BLDG
研究楼持续翻新
  • 批准号:
    6424627
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
RES BLDG RENOVATION: STD
RES 大楼翻新:标准
  • 批准号:
    6794348
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
RES BLDG RENOVATION: DIABETES
RES 大楼改造:糖尿病
  • 批准号:
    6794349
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
RES BLDG RENOVATION: CANCER
RES 大楼改造:癌症
  • 批准号:
    6794347
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
RES BLDG RENOVATION: AGING
RES 大楼改造:老化
  • 批准号:
    6794346
  • 财政年份:
    2002
  • 资助金额:
    $ 28.51万
  • 项目类别:
RENOVATION OF RESEARCH BUILDING
科研楼改造
  • 批准号:
    6254919
  • 财政年份:
    2000
  • 资助金额:
    $ 28.51万
  • 项目类别:
ASSAY FOR HAPTEN SPECIFIC PRIMING OF T LYMPHOCYTES
T 淋巴细胞半抗原特异性启动的测定
  • 批准号:
    6141416
  • 财政年份:
    1998
  • 资助金额:
    $ 28.51万
  • 项目类别:
Training Program in the Molecular Bases of Eye Disease
眼病分子基础培训计划
  • 批准号:
    6314342
  • 财政年份:
    1997
  • 资助金额:
    $ 28.51万
  • 项目类别:

相似海外基金

ACYCLOVIR RESISTANT MUCOCUTANEOUS HERPES SIMPLEX DISEASE IN AIDS
艾滋病中的阿昔洛韦耐药性皮肤粘膜单纯疱疹病
  • 批准号:
    3785780
  • 财政年份:
  • 资助金额:
    $ 28.51万
  • 项目类别:
ACYCLOVIR RESISTANT MUCOCUTANEOUS HERPES SIMPLEX DISEASE IN AIDS
艾滋病中的阿昔洛韦耐药性皮肤粘膜单纯疱疹病
  • 批准号:
    3763676
  • 财政年份:
  • 资助金额:
    $ 28.51万
  • 项目类别:
TOPICALLY APPLIED ACYCLOVIR IN GENITAL HERPES SIMPLEX DISEASE
局部应用阿昔洛韦治疗单纯性生殖器疱疹
  • 批准号:
    4697855
  • 财政年份:
  • 资助金额:
    $ 28.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了